These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35081867)

  • 1. Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.
    Liu X; Yin Z; Wu Y; Zhan Q; Huang H; Fan J
    Bioengineered; 2022 Feb; 13(2):3739-3750. PubMed ID: 35081867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
    Liu Y; Zhai R; Hu S; Liu J
    Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.
    Wei L; He W; Zhao H; Zhao P
    Anticancer Drugs; 2022 Nov; 33(10):1069-1080. PubMed ID: 36255068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
    Sheng H; Wang X
    Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
    Pang J; Ye L; Zhao D; Zhao D; Chen Q
    Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
    Gao Y; Huang Y
    J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis.
    Sun Y; Ma J; Lin J; Sun D; Song P; Shi L; Li H; Wang R; Wang Z; Liu S
    Anticancer Drugs; 2021 Oct; 32(9):950-961. PubMed ID: 34016832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer.
    Dai C; Dai SY; Gao Y; Yan T; Zhou QY; Liu SJ; Liu X; Deng DN; Wang DH; Qin QF; Zi D
    Epigenetics; 2023 Dec; 18(1):2175565. PubMed ID: 36908025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer.
    Yin Y; Li J; Rong J; Zhang B; Wang X; Han H
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):261-274. PubMed ID: 35179434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
    Sun G; Tian J; Xiao Y; Zeng Y
    Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
    Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
    Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Yao W; Guo P; Mu Q; Wang Y
    Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
    [No Abstract]   [Full Text] [Related]  

  • 14. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
    Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
    Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
    Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
    J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
    Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
    Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
    [No Abstract]   [Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.
    You J; Han Y; Qiao H; Han Y; Lu X; Lu Y; Wang X; Kai H; Zheng Y
    Aging (Albany NY); 2022 Jun; 14(11):4699-4713. PubMed ID: 35687899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.